ATP6AP1 and breast cancer: BC patients with higher ATP6AP1 levels had poorer prognoses, whether they had enriched or reduced levels of B cells, CD4+ T cells, eosinophils, macrophages, mesenchymal stem cells, natural killer T cells, Th1 cells or Th2 cells (all P < 0.05).